These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8036490)

  • 1. E. coli scare spawns therapy search.
    Service RF
    Science; 1994 Jul; 265(5171):475. PubMed ID: 8036490
    [No Abstract]   [Full Text] [Related]  

  • 2. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.
    Griffin PM; Tauxe RV
    Epidemiol Rev; 1991; 13():60-98. PubMed ID: 1765120
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemorrhagic colitis and hemolytic-uremic syndrome--E. coli as the etiologic agent. I. Bacteriology and pathogenesis].
    Tschäpe H; Böhme G
    Kinderarztl Prax; 1991 Jun; 59(6):161-5. PubMed ID: 1921166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shigella and Shiga toxin-producing Escherichia coli causing bloody diarrhea in Latin America.
    López EL; Prado-Jiménez V; O'Ryan-Gallardo M; Contrini MM
    Infect Dis Clin North Am; 2000 Mar; 14(1):41-65, viii. PubMed ID: 10738672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2.
    Chart H; Law D; Rowe B; Acheson DW
    J Clin Pathol; 1993 Nov; 46(11):1053-4. PubMed ID: 8254096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic uremic syndrome due to shiga-like toxin producing Escherichia coli 048:H21 in South Australia.
    Goldwater PN; Bettelheim KA
    Emerg Infect Dis; 1995; 1(4):132-3. PubMed ID: 8903183
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diseases caused by verotoxigenic Escherichia coli].
    Ambrozová H; Srámková L; Bielaszewská M
    Cesk Pediatr; 1990 Jan; 45(1):29-30. PubMed ID: 2203548
    [No Abstract]   [Full Text] [Related]  

  • 8. [The old and new problems of the antibiotics treatment in hemorrhagic enterocolitis and hemolytic uremic syndrome, according to Japanese epidemiological studies].
    Kohsaka T; Tagawa M; Suzuki T; Ito H
    Nihon Rinsho; 1997 Mar; 55(3):706-14. PubMed ID: 9086785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease.
    Cohen A; Madrid-Marina V; Estrov Z; Freedman MH; Lingwood CA; Dosch HM
    Int Immunol; 1990; 2(1):1-8. PubMed ID: 1965141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological identification of infection by verocytotoxin-producing Escherichia coli.
    Chart H; Cheasty T; Rowe B
    Lett Appl Microbiol; 1996 Nov; 23(5):322-4. PubMed ID: 8987714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins.
    Lopez EL; Diaz M; Grinstein S; Devoto S; Mendilaharzu F; Murray BE; Ashkenazi S; Rubeglio E; Woloj M; Vasquez M
    J Infect Dis; 1989 Sep; 160(3):469-75. PubMed ID: 2668430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verocytotoxigenic Escherichia coli serologic responses in patients with hemolytic uremic syndrome.
    Goldwater PN; Bettelheim KA
    J Infect Dis; 2002 Aug; 186(4):582; author reply 582-3. PubMed ID: 12195391
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemolytic uremic syndrome and E coli infections producing verotoxins: a public health problem].
    Loirat C
    Arch Pediatr; 1996; 3 Suppl 1():342s-344s. PubMed ID: 8796071
    [No Abstract]   [Full Text] [Related]  

  • 14. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.
    O'Brien AD; Tesh VL; Donohue-Rolfe A; Jackson MP; Olsnes S; Sandvig K; Lindberg AA; Keusch GT
    Curr Top Microbiol Immunol; 1992; 180():65-94. PubMed ID: 1324134
    [No Abstract]   [Full Text] [Related]  

  • 15. The nature of immunity to the Escherichia coli Shiga toxins (verocytotoxins) and options for toxoid immunization.
    Karmali MA
    Jpn J Med Sci Biol; 1998; 51 Suppl():S26-35. PubMed ID: 10211434
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis of infections with Shiga-like toxin-producing Escherichia coli by use of enzyme-linked immunosorbent assays for Shiga-like toxins on cultured stool samples.
    Law D; Hamour AA; Acheson DW; Panigrahi H; Ganguli LA; Denning DW
    J Med Microbiol; 1994 Apr; 40(4):241-5. PubMed ID: 8151673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Verotoxin-producing E. coli in children with hemolytic-uremic syndrome and diarrhea].
    Bielaszewská M
    Cesk Pediatr; 1993 May; 48(5):295-7. PubMed ID: 8374971
    [No Abstract]   [Full Text] [Related]  

  • 18. Verocytotoxin producing Escherichia coli.
    Brook MG; Bannister BA
    BMJ; 1991 Oct; 303(6806):800-1. PubMed ID: 1932966
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome.
    Arbus GS
    Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence associating hemolytic uremic syndrome with infection by Verotoxin-producing Escherichia coli O157:H7.
    Gransden WR; Damm MA; Anderson JD; Carter JE; Lior H
    J Infect Dis; 1986 Sep; 154(3):522-4. PubMed ID: 3525698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.